Forgot your password?
New user?
Nanoparticle fear over anti-odour socks
Fragment-based Lead Discovery Conference 2008
test conference
Document Actions
CHI’S POST-APPROVAL DRUG SAFETY STRATEGIES
| Type | Conference |
|---|---|
| Date |
November 12, 2008
to November 14, 2008 |
| Venue |
Ritz-Carlton, Pentagon City Arlington, VA US |
| Chemistry Specialties |
|
| Chemistry Techniques |
|
| Contact |
CHI Representative Cambridge Healthtech Institute 250 First Ave Needham, MA 02494 US 781 972 5400 781 972 5425 chI@healthtech.com |
| Add event to calendar |
vCal (Windows, Linux)
iCal (Mac OS X)
|
Improving products’ effective clinical safety will increase the industry’s fundamental value proposition to patients, healthcare providers, payors and regulators. The program will focus on pharmacovigilance program implementation and specific strategies and approaches to creating true value from a peri- and post-approval drug safety program. Drug safety programs and monitoring and the approach of this conference are not to look at safety in the silos of early-phase safety or post-approval safety but to view safety holistically, across the lifecycle, especially at the transition from approval to broader use in the marketplace. www.healthtech.com